A forum for researchers, students and applicants in the field of cyclodextrin technology
This second-generation delivery device provides a cost-efficient alternative to in-hospital treatment. Lasix® ONYU represents the most recent FDA-approved formulation incorporating
This study shows the results of the operational design to build a prototype for the retention at lab scale of
In order to develop cyclodextrin derivatives having improved aqueous solubility, high solubilizing power, and low accumulation upon longer administration charged
